Savient Pharmaceuticals Inc- Strategy and SWOT Report
MarketLine, August 2011, Pages: 36
Savient Pharmaceuticals Inc - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Savient Pharmaceuticals Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Savient Pharmaceuticals Inc in the form of a SWOT analysis
- An in-depth view of the business model of Savient Pharmaceuticals Inc including a breakdown and examination of key business segments
- Intelligence on Savient Pharmaceuticals Inc’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Savient Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Savient Pharmaceuticals (Savient) is a specialty biopharmaceutical company engaged in developing KRYSTEXXA (pegloticase) for the treatment of chronic gout in patients’ refractory to conventional therapy. It also manufactures and supplies Oxandrin (oxandrolone) in the US. The company operates in the US. It is headquartered in East Brunswick, New Jersey and employed 129 people as of February 24, 2011. The company recorded revenues of $4 million during the financial year ended December 2010 (FY2010), an increase of 36.1% over FY2009. The operating loss of the company was $56 million during FY2010, as compared to operating loss of $81.2 million in FY2009. The net loss was $73.1 million in FY2010, as compared to net loss of $90.9 million in FY2009.
Reasons to Purchase:
- Gain understanding of Savient Pharmaceuticals Inc and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Savient Pharmaceuticals Inc as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Savient Pharmaceuticals Inc’s business structure, strategy and prospects
Company Snapshot
Savient Pharmaceuticals Inc: Company Overview
Savient Pharmaceuticals Inc: Overview and Key Facts
Savient Pharmaceuticals Inc: Overview
Savient Pharmaceuticals Inc: Key Facts
Savient Pharmaceuticals Inc: Key Employees
Savient Pharmaceuticals Inc: Key Employee Biographies
Savient Pharmaceuticals Inc: Major Products and Services
Savient Pharmaceuticals Inc: Company History
Savient Pharmaceuticals Inc: Locations and Subsidiaries
Savient Pharmaceuticals Inc: Key Competitors Savient Pharmaceuticals Inc: Company Analysis
Savient Pharmaceuticals Inc: Business Description
Savient Pharmaceuticals Inc: SWOT Analysis
Savient Pharmaceuticals Inc: SWOT Overview
Savient Pharmaceuticals Inc: Strengths
Savient Pharmaceuticals Inc: Weaknesses
Savient Pharmaceuticals Inc: Opportunities
Savient Pharmaceuticals Inc: Threats
Savient Pharmaceuticals Inc: Corporate Financial Deals Activity
Savient Pharmaceuticals Inc: Financial Deals Overview
Savient Pharmaceuticals Inc: Targets and Partners
Savient Pharmaceuticals Inc: Top Deals 2007 -YTD-2012
Savient Pharmaceuticals Inc: Advisors
Savient Pharmaceuticals Inc: Top Financial Advisors
Savient Pharmaceuticals Inc: Capital Raising
Savient Pharmaceuticals Inc: Partnership Savient Pharmaceuticals Inc: Recent Developments
Savient Pharmaceuticals Inc: News and Events Summary
Savient Pharmaceuticals Inc: Business Expansion
Savient Pharmaceuticals Inc: Corporate Governance
Savient Pharmaceuticals Inc: Financial Performance
Savient Pharmaceuticals Inc: Regulatory and Legal Events
Savient Pharmaceuticals Inc: Research & Development Appendix
Contact Us
Methodology
Definitions
About Datamonitor List of Tables Table 1: Savient Pharmaceuticals Inc: Key Facts Table 2: Savient Pharmaceuticals Inc: Key Employees Table 4: Savient Pharmaceuticals Inc: Key Competitors Table 5: Savient Pharmaceuticals Inc: Deal Activity by Deal Type - Volume (2008 - YTD-2012) Table 6: Savient Pharmaceuticals Inc: Targets and Partners Table 7: Savient Pharmaceuticals Inc: Top Deals 2007 -YTD-2012 Table 8: Savient Pharmaceuticals Inc: Financial Advisor Ranking by Value (US$m) Table 9: Savient Pharmaceuticals Inc: Capital Raising Volume and Value Trend (2008 - YTD-2012) Table 10: Savient Pharmaceuticals Inc: Capital Raising by Deal Type (2008 - YTD-2012) Table 11: Savient Pharmaceuticals Inc: Partnership Volume and Value Trend (2008 - YTD-2012) Table 12: Savient Pharmaceuticals Inc: Partnership Trend by Deal Type (2008 - YTD-2012) Table 13: Savient Pharmaceuticals Inc: News and Events Summary Table 14: Savient Pharmaceuticals Inc: Business Expansion Table 15: Savient Pharmaceuticals Inc: Corporate Governance Table 16: Savient Pharmaceuticals Inc: Financial Performance Table 17: Savient Pharmaceuticals Inc: Regulatory and Legal Events Table 18: Savient Pharmaceuticals Inc: Research & Development List of Figures Figure 1: Savient Pharmaceuticals Inc: Deal Activity by Deal Type - Volume (2008 - YTD-2012) Figure 2: Savient Pharmaceuticals Inc: Capital Raising Volume and Value Trend (2008 - YTD-2012) Figure 3: Savient Pharmaceuticals Inc: Capital Raising by Deal Type (2008 - YTD-2012) Figure 4: Savient Pharmaceuticals Inc: Partnership Volume and Value Trend (2008 - YTD-2012) Figure 5: Savient Pharmaceuticals Inc: Partnership Trend by Deal Type (2008 - YTD-2012)
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
